» Articles » PMID: 29097306

Conserved Structural and Functional Aspects of the Tripartite Motif Gene Family Point Towards Therapeutic Applications in Multiple Diseases

Overview
Journal Pharmacol Ther
Specialty Pharmacology
Date 2017 Nov 4
PMID 29097306
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The tripartite motif (TRIM) gene family is a highly conserved group of E3 ubiquitin ligase proteins that can establish substrate specificity for the ubiquitin-proteasome complex and also have proteasome-independent functions. While several family members were studied previously, it is relatively recent that over 80 genes, based on sequence homology, were grouped to establish the TRIM gene family. Functional studies of various TRIM genes linked these proteins to modulation of inflammatory responses showing that they can contribute to a wide variety of disease states including cardiovascular, neurological and musculoskeletal diseases, as well as various forms of cancer. Given the fundamental role of the ubiquitin-proteasome complex in protein turnover and the importance of this regulation in most aspects of cellular physiology, it is not surprising that TRIM proteins display a wide spectrum of functions in a variety of cellular processes. This broad range of function and the highly conserved primary amino acid sequence of family members, particularly in the canonical TRIM E3 ubiquitin ligase domain, complicates the development of therapeutics that specifically target these proteins. A more comprehensive understanding of the structure and function of TRIM proteins will help guide therapeutic development for a number of different diseases. This review summarizes the structural organization of TRIM proteins, their domain architecture, common and unique post-translational modifications within the family, and potential binding partners and targets. Further discussion is provided on efforts to target TRIM proteins as therapeutic agents and how our increasing understanding of the nature of TRIM proteins can guide discovery of other therapeutics in the future.

Citing Articles

The Role and Mechanism of TRIM Proteins in Gastric Cancer.

Wu W, Yang J, Yu T, Zou Z, Huang X Cells. 2025; 13(24.

PMID: 39768197 PMC: 11674240. DOI: 10.3390/cells13242107.


Redirecting E3 ubiquitin ligases for targeted protein degradation with heterologous recognition domains.

Yang H, Zheng G, Li G, Alshaye A, Orkin S J Biol Chem. 2024; 301(1):108077.

PMID: 39675716 PMC: 11758572. DOI: 10.1016/j.jbc.2024.108077.


E3 Ubiquitin Ligases and Their Therapeutic Applications in Cancers: Narrative Review.

Jamal A J Pharm Bioallied Sci. 2024; 16(Suppl 3):S1984-S1986.

PMID: 39346323 PMC: 11426868. DOI: 10.4103/jpbs.jpbs_134_24.


TRIM8 as a predictor for prognosis in childhood acute lymphoblastic leukemia based on a signature of neutrophil extracellular traps.

Tin W, Xiao C, Sun K, Zhao Y, Xie M, Zheng J Front Oncol. 2024; 14:1427776.

PMID: 39224802 PMC: 11366590. DOI: 10.3389/fonc.2024.1427776.


Effects of Gene Alternative Splicing Events on Resistance to Cryptocaryonosis of Large Yellow Croaker (Larimichthys crocea).

Li X, Ke Q, Qu A, Wang J, Zhao J, Xu P Mar Biotechnol (NY). 2024; 26(4):741-753.

PMID: 38969905 DOI: 10.1007/s10126-024-10342-8.


References
1.
Mandell M, Jain A, Arko-Mensah J, Chauhan S, Kimura T, Dinkins C . TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev Cell. 2014; 30(4):394-409. PMC: 4146662. DOI: 10.1016/j.devcel.2014.06.013. View

2.
Frosk P, Weiler T, Nylen E, Sudha T, Greenberg C, Morgan K . Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 2002; 70(3):663-72. PMC: 447621. DOI: 10.1086/339083. View

3.
Rajsbaum R, Albrecht R, Wang M, Maharaj N, Versteeg G, Nistal-Villan E . Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog. 2012; 8(11):e1003059. PMC: 3510253. DOI: 10.1371/journal.ppat.1003059. View

4.
Ran Y, Zhang J, Liu L, Pan Z, Nie Y, Zhang H . Autoubiquitination of TRIM26 links TBK1 to NEMO in RLR-mediated innate antiviral immune response. J Mol Cell Biol. 2015; 8(1):31-43. DOI: 10.1093/jmcb/mjv068. View

5.
Lee O, Lee J, Lee K, Woo Y, Kang J, Yoon H . Role of the focal adhesion protein TRIM15 in colon cancer development. Biochim Biophys Acta. 2014; 1853(2):409-21. DOI: 10.1016/j.bbamcr.2014.11.007. View